Abstract
Primary systemic vasculitic diseases are relatively rare. Untreated, they have a high morbidity and mortality. The introduction of steroids and cytotoxic drugs has dramatically reduced the mortality.
In a retrospective study in a Norwegian community hospital, which serves a county with a population of 150 426 in 1996, 68 patients were found to have a primary vasculitis, 63 of whom fulfilled the ACR 1990 criteria. Patients with Henoch-Schönlein purpura aged less than 16 years and patients with Kawasaki's disease were excluded. The overall prevalence was 43.9 per 100 000 inhabitants (Churg-Strauss syndrome 1.3, hypersensitivity vasculitis 2.7, Henoch-Schönlein purpura 3.3, polyarteritis nodosa 3.3, Wegener's granulomatosis 5.3 and temporal arteritis 27.9). In most cases, disease control was achieved with corticosteroids alone, or with the addition of cytotoxic drugs. Two patients had died in the latest 5-year period but of unrelated disorders. Biopsy plays a major role in diagnosing vasculitic disease. In our study, 62 patients had a positive biopsy supporting the diagnosis.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Lie JT. Diagnostic histopathology of major systemic and pulmonary vasculitic syndromes. Rheum Dis Clin North Am 1990;16:269–92.
Cupps TR. Vasculitis masquerading as vasculitis. Mayo Clin Proc 1993;68:194–6.
Fries JF, Hunder GG, Bloch DA, Michel BA, Arend WP, Calabrese LH, et al. The American College of Rheumatology 1990 criteria for the classification of vasculitis. Summary. Arthritis Rheum 1990;33:1135–6.
Michel BA. Classification of vasculitis. Curr Opin Rheumatol 1992;4:3–8.
Nishino H, DeRemee RA, Rubino FA, Parisi JE. Wegener's granulomatosis associated with vasculitis of the temporal artery: report of five cases. Mayo Clin Proc 1993;68:115–21.
Jennette JC, Falk RJ: Clinical and pathological classification of ANCA-associated vasculitis: what are the controversies. Clin Exp Immunol 1995;1(suppl 101):18–22.
Jennette JC, Falk RJ, Andrassy K, Bacon PA, Churg J, Gross WL, et al. Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum 1994;37:187–92.
Kallenberg CGM, Brouwer E, Weening JJ, Cohen Tervaert JWC. Anti-neutrophil cytoplasmic antibodies: current diagnostic and pathophysiologic potential. Kidney Int 1994;46:1–15.
Jenette JC, Falk RJ. Anti-neutrophil cytoplasmic autoantibodies and associated diseases: a review. Am J Kidney Dis 1990;15:517–29.
Cohen-Tervaert JW, Limburg PC, Elema JD, Huitema MG, Horst G, The TH, Kallenberg CG. Detection of autoantibodies against myeloid lysomal enzymes: a useful adjunct to classification of patients with biopsy-proven necrotizing arteritis. Am J Med 1991;91:59–66.
Haugeberg G, Bie R, Johnsen V. Vasculitic changes in the temporal artery in polyarteritis nodosa: report of five cases. Scand J Rheumatol 1997;26:383–5.
Arend WP, Michel BA, Bloch DA, Hunder GG, Calabrese LH, Edworthy SM, et al. The American College of Rheumatology 1990 criteria for the classification of Takayasu arteritis. Arthritis Rheum 1990;33:1129–34.
Gene GG, Bloch DA, Michel BA, Stevens MB, Arend WP, Calabrese LH, et al. The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum 1990;33:1122–8.
Mills JA, Michel BA, Bloch DA, Calabrese LH, Hunder GG, Arend WP, et al. The American College of Rheumatology 1990 criteria for the classification of Henoch-Schönlein purpura. Arthritis Rheum 1990;33:1114–21.
Lie JT. Illustrated histopathologic classification criteria for selected vasculitis syndromes. Arthritis Rheum 1990;33:1074–87.
Lie JT. When is arteritis of the temporal arteries not temporal arteritis? (editorial). J Rheumatol 1994;21:186–9.
Lie JT. Histopathologic specificity of systemic vasculitis (review). Rheum Dis Clin North Am 1995;21:883–909.
Goldman R, Adams WS, Beck WS, Levin M, Bassett SH, White A. The effect of ACTH on one case of periarteritis nodosa. In: Mote JR, editor. Proceedings of the First Clinical ACTH Conference. Philadelphia: Blakiston, 1950:437.
Baggenstoss AH, Shick RM, Polley HF. The effect of cortisone on the lesions of periarteritis nodosa. (abstract). Am J Pathol 1950;26:709.
Frohnert PP, Sheps SG. Long-term follow-up study of periarteritis nodosa. Am J Med 1967;43:8–14.
Leib ES, Restivo C, Paulus HE. Immunosuppressive and corticosteroid therapy of polyarteritis nodosa. Am J Med 1979;67:941–7.
Walton EW. Giant cell granuloma of the respiratory tract (Wegener's granulomatosis). Br Med J 1958;2:265–70.
Hoffman GS, Kerr GS, Leavitr RY, Hallahan CW, Lebovics RS, Travis WD, et al. Wegener's granulomatosis: an analysis of 158 patients. Ann Intern Med 1992;116:488–98.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Haugeberg, G., Bie, R., Bendvold, A. et al. Primary vasculitis in a Norwegian community hospital: A retrospective study. Clin Rheumatol 17, 364–368 (1998). https://doi.org/10.1007/BF01450893
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01450893